Access to patient-level data from GlaxoSmithKline clinical trials

New England Journal of Medicine

Volumn 369, Issue 5, 2013, Pages 475-478

  Nisen, Perry ^a   Rockhold, Frank ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCESS TO INFORMATION; ARTICLE; CLINICAL TRIAL (TOPIC); CONFIDENTIALITY; DATA ANALYSIS; DECISION MAKING; DOCUMENT EXAMINATION; HUMAN; INFORMATION SEEKING; MEDICAL DOCUMENTATION; MEDICAL LITERATURE; MEDICAL RESEARCH; PRIORITY JOURNAL; PRIVACY; PUBLICATION;

EID: 84880893300     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMsr1302541     Document Type: Article

References (2)

1. Data Protection Working Party. Opinion 4/2007 on the concept of personal data (http://ec.europa.eu/justice/policies/privacy/docs/wpdocs/2007/wp136-en. pdf).
2. Other requirements relating to uses and disclosures of protected health information, 45 C.F.R. § 164.514 (http://www.gpo.gov/fdsys/pkg/CFR-2012- title45-vol1/xml/CFR-2012-title45-vol1-sec164-514.xml).